Dr. Vaishali Rupen Baxi, MD

Dr. Baxi practices at Compassionate Specialty Clinic in Bethesda, Maryland.

Dr. Baxi's NPI, 1457672727, was assigned on June 21, 2010. Dr. Baxi holds Maryland license 82035.

Dr. Baxi's primary practice is Compassionate Specialty Clinic, at 10319 Westlake Dr, Bethesda, MD 20817 in Montgomery County. The practice phone is (301) 902-0664.

Dr. Baxi's primary practice is Compassionate Specialty Clinic in Bethesda, Maryland. Dr. Baxi is also affiliated with Holy Cross Hospital. The medical group on file is Emergency Medicine Physicians (EMP). Dmand AI also links Dr. Baxi to 2 more hospitals, 6 medical groups, 2 group practices and clinics, 1 hospice and 1 skilled nursing facility, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Baxi practices, 7 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Baxi's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. Baxi's licenses on file in 2 states: Maryland and New York.

CMS data shows 1,029 Medicare services from Dr. Baxi across 5 procedure codes in 2024, for 518 Medicare patients. Medicare paid $102,054 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 518 Medicare patients who saw Dr. Baxi in 2024. The largest group is 75 to 84, with 198 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 33% are also on Medicaid. Their average risk score is 2.76, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Baxi's median patient age at 73, with 52% women.

In 2024, Dr. Baxi wrote 244 Medicare Part D claims for 91 patients. 93% of them were for generic drugs. CMS names the drug for 64 of them, across 4 drugs with 11 or more claims each, at $558 in total drug cost. In 2021, CMS named 44 claims across 3 drugs.

Dr. Baxi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 29 general payments to Dr. Baxi from 11 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $240.